Rethinking Diabetes: A Weekly Review
Malattie Metaboliche e Diabetologia
Diabetes Innovations: From Medications to Monitoring
This week we explore groundbreaking diabetes research, from cardiovascular benefits of new medications to stem cell therapies and advanced diagnostic techniques. Our hosts discuss key findings from recent studies that could transform diabetes care.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. Effect of Medications for Type 2 Diabetes on Cardiovascular Events and Mortality: A Comprehensive Pairwise and Network Meta-Analysis.
Authors: Silverii GA, Velardi V, Marinelli C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42530338
DOI: 10.1111/dom.71128
2. Real-World Databases in Diabetes: A Systematic Review.
Authors: Thomas JJC, Meffen A, Rizzi A, et al.
Journal: Diabetes/metabolism research and reviews, 2026 Oct
PMID: 42885326
DOI: 10.1002/dmrr.70241
3. Intensity matters: high-intensity interval resistance exercise induces greater immune activation than low-intensity resistance exercise 45 min post-workout.
Authors: Fabritius F, Rißmayer M, Ringleb M, et al.
Journal: European journal of applied physiology, 2026 Oct
PMID: 42461394
DOI: 10.1007/s00421-026-06337-z
4. Aldosterone synthase inhibitors: biological rationale, mechanism of action, and results of clinical trials.
Authors: Surma S, Narkiewicz K
Journal: American journal of hypertension, 2026 Oct 1
PMID: 42847230
DOI: 10.1093/ajh/hpag087
5. Safety and efficacy of human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes: a double-blind, randomized, placebo-controlled, phase 1 trial.
Authors: Tang Q, Zhou L, Fan L, et al.
Journal: Signal transduction and targeted therapy, 2026 Sep 30
PMID: 42816465
DOI: 10.1038/s41392-026-03021-8
6. Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.
Authors: Audrain E, Bel Lassen P, Bellanné-Chantelot C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42559753
DOI: 10.1111/dom.71169
7. Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study.
Authors: Zanfardino A, Iafusco D, Ippolito G, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42488981
DOI: 10.1111/dom.71101
8. Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
Authors: Ipek R, Schaefer E, Neuenschwander M, et al.
Journal: Pharmacology & therapeutics, 2026 Oct
PMID: 42471062
DOI: 10.1016/j.pharmthera.2026.109083
9. Rare Causes of Pediatric Primary Adrenal Insufficiency: An Observational Cohort Study.
Authors: Schermesser-Sicard M, Samara-Boustani D, Roucher-Boulez F, et al.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026 Oct
PMID: 42142624
DOI: 10.1016/j.eprac.2026.05.011
10. 68Ga-DOTA-exendin-4 PET/CT for insulinoma localization in patients with negative or inconclusive conventional imaging.
Authors: Fricke JG, Laubner K, Schildmeijer M, et al.
Journal: The Journal of clinical endocrinology and metabolism, 2026 Oct 16
PMID: 42168767
DOI: 10.1210/clinem/dgag214
Authors: Silverii GA, Velardi V, Marinelli C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42530338
DOI: 10.1111/dom.71128
2. Real-World Databases in Diabetes: A Systematic Review.
Authors: Thomas JJC, Meffen A, Rizzi A, et al.
Journal: Diabetes/metabolism research and reviews, 2026 Oct
PMID: 42885326
DOI: 10.1002/dmrr.70241
3. Intensity matters: high-intensity interval resistance exercise induces greater immune activation than low-intensity resistance exercise 45 min post-workout.
Authors: Fabritius F, Rißmayer M, Ringleb M, et al.
Journal: European journal of applied physiology, 2026 Oct
PMID: 42461394
DOI: 10.1007/s00421-026-06337-z
4. Aldosterone synthase inhibitors: biological rationale, mechanism of action, and results of clinical trials.
Authors: Surma S, Narkiewicz K
Journal: American journal of hypertension, 2026 Oct 1
PMID: 42847230
DOI: 10.1093/ajh/hpag087
5. Safety and efficacy of human gingiva-derived mesenchymal stem cells in patients with type 1 diabetes: a double-blind, randomized, placebo-controlled, phase 1 trial.
Authors: Tang Q, Zhou L, Fan L, et al.
Journal: Signal transduction and targeted therapy, 2026 Sep 30
PMID: 42816465
DOI: 10.1038/s41392-026-03021-8
6. Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.
Authors: Audrain E, Bel Lassen P, Bellanné-Chantelot C, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42559753
DOI: 10.1111/dom.71169
7. Real-World Effectiveness and Safety of a Tubeless Automated Insulin Delivery System With an Adaptive Control Algorithm (APGO) in Children and Adolescents With Type 1 Diabetes: A Multicentre Observational Study.
Authors: Zanfardino A, Iafusco D, Ippolito G, et al.
Journal: Diabetes, obesity & metabolism, 2026 Oct
PMID: 42488981
DOI: 10.1111/dom.71101
8. Prognostic factors for mortality in ST-elevation myocardial infarction in individuals with diabetes: A systematic review with implications for risk stratification and therapeutic considerations.
Authors: Ipek R, Schaefer E, Neuenschwander M, et al.
Journal: Pharmacology & therapeutics, 2026 Oct
PMID: 42471062
DOI: 10.1016/j.pharmthera.2026.109083
9. Rare Causes of Pediatric Primary Adrenal Insufficiency: An Observational Cohort Study.
Authors: Schermesser-Sicard M, Samara-Boustani D, Roucher-Boulez F, et al.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2026 Oct
PMID: 42142624
DOI: 10.1016/j.eprac.2026.05.011
10. 68Ga-DOTA-exendin-4 PET/CT for insulinoma localization in patients with negative or inconclusive conventional imaging.
Authors: Fricke JG, Laubner K, Schildmeijer M, et al.
Journal: The Journal of clinical endocrinology and metabolism, 2026 Oct 16
PMID: 42168767
DOI: 10.1210/clinem/dgag214
